Home › Kanser sa Bato (Renal Cell Carcinoma) › Pennsylvania › Pittsburgh
Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa Pittsburgh, PA
Isang pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Pittsburgh. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Nagre-recruitPhase 1
- Research Site, Pittsburgh
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Nagre-recruitPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Nagre-recruitPhase 1/2
- UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #32, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- at 2 pa
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Nagre-recruitPhase 2
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- at 14 pa
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Nagre-recruitPhase 3
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- at 3 pa
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site, Pittsburgh
Autologous Dendritic Cell Vaccine in Kidney Cancer
Nagre-recruitPhase 2
- UPMC Department of Urology, Pittsburgh
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Nagre-recruitPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Nagre-recruitPhase 1
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Nagre-recruitPhase 1/2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Nagre-recruitPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
Nagre-recruitPhase 1
- UPMC- Hillman Cancer Center, Pittsburgh
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Nagre-recruitPhase 3
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
- at 9 pa
Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod
- Houston, TX35 pag-aaral
- New York City, NY27 pag-aaral
- Nashville, TN23 pag-aaral
- Dallas, TX23 pag-aaral
- St. Louis, MO23 pag-aaral
- Los Angeles, CA20 pag-aaral
- Boston, MA16 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Philadelphia, PA15 pag-aaral
- Queens, NY15 pag-aaral
- Cleveland, OH14 pag-aaral
- Jacksonville, FL14 pag-aaral
Iba pang pag-aaral sa Pittsburgh
- Non-Small Cell Lung Cancer48 pag-aaral
- Kanser (lahat ng uri)41 pag-aaral
- Kanser sa Suso39 pag-aaral
- Colorectal Cancer32 pag-aaral
- Metastatic Cancer31 pag-aaral
- Melanoma31 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Kanser ng Endometrium23 pag-aaral
- Kanser sa Prostate23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg22 pag-aaral
- Stroke22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.